UK Health Security Agency News and Media

08 Aug 2023

Autumn booster: JCVI advises on eligibility groups for 2023/24 programme

The JCVI today announces its advice regarding the persons who will be eligible for a COVID-19 booster vaccine in autumn 2023.  This follows interim advice published in January.

The COVID-19 vaccination programme is now entering its third autumn season. Vaccination helps to protect against severe illness, hospitalisations and deaths from COVID-19.

The advice for this autumn is to offer the vaccine to those at high risk of serious disease and who are therefore most likely to benefit from vaccination.

Specifically, JCVI advises the following groups be offered a COVID-19 booster vaccine this autumn:

  • Residents in a care home for older adults
  • All adults aged 65 years and over
  • Persons aged 6 months to 64 years in a clinical risk group, as laid out in the Immunisation Green Book,COVID-19 Chapter (Green Book)
  • Frontline health and social care workers
  • Persons aged 12 to 64 years who are household contacts (as defined in the Green Book) of people with immunosuppression
  • Persons aged 16 to 64 years who are carers (as defined in the Green Book) and staff working in care homes for older adults

Further advice on the choice of vaccine products for use this autumn will be provided in due course.

Professor Wei Shen Lim, Chair of COVID-19 immunisation on the JCVI, said:

“The autumn booster programme will continue to focus on those at greatest risk of getting seriously ill. These persons will benefit the most from a booster vaccination.

“It is important that everyone who is eligible takes up a booster this autumn - helping to prevent them from hospitalisations and deaths arising from the virus over the winter months.”

Dr Mary Ramsay, Director of Public Health Programmes at UKHSA, said:

“The COVID-19 virus has not gone away and we expect to see it circulating more widely over the winter months with the numbers of people getting ill increasing.

“The booster is being offered to those at higher risk of severe illness and by taking up the booster vaccine this autumn, you will increase your protection ahead of winter, when respiratory viruses are typically at their peak.”

To optimise protection over the winter months, JCVI advises that the autumn programme should aim to complete vaccinations by early December 2023 ahead of winter, mindful that protection is highest in the first 3 months following vaccination. This will help maximise the potential benefits of the programme.

At the same time, JCVI recognises some need for operational flexibility in relation to when these vaccines will be offered, taking into consideration factors such as vaccine supply.

From autumn 2023, JCVI additionally advises that primary course COVID-19 vaccination for persons who have not had any COVID-19 vaccines before should consist of a single dose of COVID-19 vaccine. Eligibility for primary course vaccination will be the same as for the autumn 2023 booster.

Last year’s autumn booster programme ended on the 20 February 2023. Data up to 12 March showed that 73.2% of 65-70 year olds in England had been vaccinated and this increased in older cohorts rising to 83.7% (just under 2.5m) in the over 80s.

Data from last autumn’s programme showed that those who received a booster were around 53% less likely to be admitted to hospital with COVID-19 in the two to four weeks following vaccination, compared to those who did not receive a booster.

NHS England will confirm details on how and when eligible people can access the autumn booster vaccine in due course.

Ends

Contact Information

Chris Hewett
UK Health Security Agency
chris.hewett@ukhsa.gov.uk

Notes to editors

JCVI Autumn Booster 2023 advice to Government: https://www.gov.uk/government/publications/covid-19-autumn-2023-vaccination-programme-jcvi-advice-26-may-2023 

Those in clinical risk groups eligible for the autumn booster (aged over 16) include:

  • Chronic respiratory disease
  • Chronic respiratory disease
  • Chronic kidney disease
  • Chronic neurological disease, such as stroke and individuals with cerebral palsy, profound multiple learning disabilities, Down’s syndrome, multiple sclerosis, epilepsy, dementia, Parkinson’s disease, motor neurone disease and related or similar conditions.
  • Diabetes
  • Those with immunosuppression
  • Asplenia or dysfunction of the spleen
  • Morbid obesity
  • Severe mental illness
  • Younger adults in long-stay nursing and residential care settings
  • Pregnant women
  • The COVID-19 Chapter in the Immunisation Green Book (Chapter14a) also lists a similar but separate table of eligible groups aged under 16 (see Table 4)